Patents by Inventor Mark R. Andersen

Mark R. Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8323897
    Abstract: The present invention provides methods, reagents and kits for carrying out a variety of assays suitable for analyzing polynucleotides or samples that include an amplification step performed in a multiplex fashion. Also provided are methods for analyzing and improving the efficiency of amplification and for carrying out gene expression analysis.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: December 4, 2012
    Assignee: Applied Biosystems, LLC
    Inventors: Mark R. Andersen, David W. Ruff
  • Publication number: 20110143343
    Abstract: Ligation-based methods and kits are disclosed for determining the degree of methylation of one or more target nucleotides. In certain embodiments, the methylation status of one or more target nucleotides is determined by generating misligation products. In certain embodiments, at least one target nucleotide is amplified prior to the ligation reaction. In certain embodiments, at least one ligation product, at least one ligation product surrogate, at least one misligation product, at least one misligation product surrogate, or combinations thereof are amplified. In certain embodiments, one or more ligation probes comprise at least one nucleotide analog, at least one Modification, at least one mismatched nucleotide, or combinations thereof.
    Type: Application
    Filed: July 26, 2010
    Publication date: June 16, 2011
    Applicant: Applied Biosystems, LLC
    Inventors: MARK R. ANDERSEN, JER-KANG CHEN, MICHAEL W. HUNKAPILLER, STEVEN M. MENCHEN
  • Patent number: 7601821
    Abstract: The present invention is directed to methods, reagents, and kits for detecting the presence or absence of (or quantifying) target polynucleotide sequences and proteins in at least one sample using encoding and decoding reactions. When a particular target polynucleotide is present in a sample for example, a reaction product is formed in the encoding reaction that includes addressable primer portions. At least one labeling probe and at least one address primer can be employed in the decoding amplification reaction thereby providing a detectable signal value depending upon whether a sequence is present or absent. In some embodiments, the encoding comprises a ligation reaction with linker probes, and single nucleotide polymorphisms (SNPs) are analyzed.
    Type: Grant
    Filed: March 24, 2005
    Date of Patent: October 13, 2009
    Assignee: Applied Biosystems, LLC
    Inventors: Mark R. Andersen, Kenneth J. Livak, Adam Broomer, Caifu Chen
  • Publication number: 20090142761
    Abstract: Ligation-based methods and kits are disclosed for determining the degree of methylation of one or more target nucleotides. In certain embodiments, the methylation status of one or more target nucleotides is determined by generating misligation products. In certain embodiments, at least one target nucleotide is amplified prior to the ligation reaction. In certain embodiments, at least one ligation product, at least one ligation product surrogate, at least one misligation product, at least one misligation product surrogate, or combinations thereof are amplified. In certain embodiments, one or more ligation probes comprise at least one nucleotide analog, at least one Modification, at least one mismatched nucleotide, or combinations thereof.
    Type: Application
    Filed: April 28, 2008
    Publication date: June 4, 2009
    Applicant: Applera Corporation
    Inventors: Mark R. Andersen, Jer-Kang Chen, Michael W. Hunkapiller, Steven M. Menchen
  • Patent number: 7364855
    Abstract: Ligation-based methods and kits are disclosed for determining the degree of methylation of one or more target nucleotides. In certain embodiments, the methylation status of one or more target nucleotides is determined by generating misligation products. In certain embodiments, at least one target nucleotide is amplified prior to the ligation reaction. In certain embodiments, at least one ligation product, at least one ligation product surrogate, at least one misligation product, at least one misligation product surrogate, or combinations thereof are amplified. In certain embodiments, one or more ligation probes comprise at least one nucleotide analog, at least one Modification, at least one mismatched nucleotide, or combinations thereof.
    Type: Grant
    Filed: May 2, 2005
    Date of Patent: April 29, 2008
    Assignee: Applera Corporation
    Inventors: Mark R. Andersen, Jer-Kang Chen, Michael W. Hunkapiller, Steven M. Menchen
  • Patent number: 7153658
    Abstract: The present invention relates to methods and kits for detecting the presence or absence of (or quantitating) target nucleic acid sequences using ligation and amplification. The invention also relates to methods, reagents, and kits that employ addressable portions and labeled probes.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: December 26, 2006
    Assignee: Applera Corporation
    Inventors: Mark R. Andersen, Michael W. Hunkapiller, Kenneth J. Livak, Eugene G. Spier, H. Michael Wenz
  • Publication number: 20040175733
    Abstract: The present invention provides methods, reagents and kits for carrying out a variety of assays suitable for analyzing polynucleotides or samples that include an amplification step performed in a multiplex fashion. Also provided are methods for analyzing and improving the efficiency of amplification and for carrying out gene expression analysis.
    Type: Application
    Filed: November 26, 2003
    Publication date: September 9, 2004
    Inventors: Mark R. Andersen, David W. Ruff
  • Publication number: 20040132051
    Abstract: Microfluidic devices are provided that are adapted to retain reactants in first and second chambers that can be in openable fluid communication with each other. The reactants can be reactants necessary to initiate, promote, or catalyze a polymerase chain reaction another nucleic acid sequence amplification, detection, ligation, or endonuclease reaction or a nucleic acid sequencing reaction. Methods and systems are also provided.
    Type: Application
    Filed: July 23, 2003
    Publication date: July 8, 2004
    Inventor: Mark R. Andersen
  • Publication number: 20040121371
    Abstract: The present invention relates to methods and kits for detecting the presence or absence of (or quantitating) target nucleic acid sequences using ligation and amplification. The invention also relates to methods, reagents, and kits that employ addressable portions and labeled probes.
    Type: Application
    Filed: September 19, 2003
    Publication date: June 24, 2004
    Applicant: Applera Corporation
    Inventors: Mark R. Andersen, Michael W. Hunkapiller, Kenneth J. Livak, Eugene G. Spier, H. Michael Wenz